FIELD: medicine.
SUBSTANCE: invention relates to medicine, specifically to a method for prediction of liver metastases in rectal cancer. Method comprises, after curative resection in hemicolectomy volume in tissue of malignant tumour in patients with rectal cancer, determining level of active form of a vascular endothelial growth factor (VEGF-A) and soluble vascular endothelial growth factor (VEGF-R), and calculating ratio thereof. If values exceeding index in intact tissue rectal mucosa 18 or more times, metastatic liver involvement is predicted in next 3.5 months.
EFFECT: use of disclosed method improves efficiency of predicting liver metastases in rectal cancer.
1 cl, 1 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR ADJUVANT CHEMOTHERAPY DURATION DETERMINATION IN CASE OF LOCALLY ADVANCED COLORECTAL CANCER WITH METASTASES IN REGIONAL LYMPH NODES AFTER RADICAL SURGERY | 2015 |
|
RU2618405C1 |
METHOD FOR PREDICTION OF DEVELOPING METASTASES IN PATIETNS SUFFERING RECTAL CANCER | 2009 |
|
RU2420742C1 |
METHOD FOR PREDICTING THE COURSE OF THE DISEASE IN PATIENTS WITH LOCAL RENAL CELL CARCINOMA OF THE KIDNEY | 2018 |
|
RU2674677C1 |
METHOD FOR PREDICTION OF DURATION OF RECURRENCE-FREE INTERVAL IN PATIENTS WITH RECTAL CANCER | 2009 |
|
RU2415429C1 |
METHOD FOR ASSESSING RISK OF PROGRESSION OF METASTATIC COLORECTAL CANCER AFTER ANTI-VEGF THERAPY | 2024 |
|
RU2823505C1 |
METHOD FOR PREDICTION OF PERITONEAL METASTASES OF GASTRIC CANCER | 2018 |
|
RU2686689C1 |
METHOD FOR PREDICTION OF LIVER METASTASES IN PATIENTS WITH COLON CANCER | 2018 |
|
RU2686687C1 |
METHOD FOR PREDICTION OF DISEASE OUTCOME IN PATIENTS WITH GASTRIC CANCER AFTER SURGICAL MANAGEMENT | 2018 |
|
RU2696054C1 |
METHOD FOR SPECIFYING DIRECTIONALITY OF PATHOLOGICAL PROCESS IN LUNG CANCER | 2009 |
|
RU2440037C2 |
METHOD OF PREDICTING DEVELOPMENT OF CEREBRAL METASTASES IN CASE OF LUNG CANCER IN WOMEN | 2009 |
|
RU2439579C2 |
Authors
Dates
2016-05-27—Published
2014-12-03—Filed